Who is sponsoring NCT02745093?

NCT02745093 is sponsored by Ibis Reproductive Health.

What condition does NCT02745093 study?

NCT02745093 studies Medical Abortion.

What drugs are being tested in NCT02745093?

Interventions: Mifepristone, Misoprostol.

What is the status of NCT02745093?

NCT02745093 is currently UNKNOWN.

Last reviewed 2016-06-16 · How we verify

The Effectiveness, Safety, and Acceptability of Home-administered Medical Abortion at Gestational Age of 8 to ≤9 Weeks Versus >9 to ≤12 Weeks: A Prospective Cohort Study in Mexico City

NCT02745093 Phase 4 UNKNOWN

The purpose of this study is to assess the effectiveness, safety, and acceptability of home-administered medical abortion at gestational age of 8 to ≤9 weeks versus \>9 to ≤12 weeks among a cohort of women in Mexico City.

Details

Lead sponsor	Ibis Reproductive Health
Phase	Phase 4
Status	UNKNOWN
Enrolment	648
Start date	2016-09
Completion	2016-12

Conditions

Medical Abortion

Interventions

Mifepristone
Misoprostol

Primary outcomes

Proportion of participants with complete abortion without surgical intervention by day 30 from mifepristone administration, regardless of misoprostol dosing, by gestational age group — 2-4 weeks

Countries

Mexico